Ben R Taylor Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Ben R Taylor is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 886,606 shares of RXRX, which is worth approximately $7.02 Million. The most recent transaction as insider was on Feb 03, 2025, when has been sold 6,544 shares (Class A Common Stock) at a price of $7.25 per share, resulting in proceeds of $47,444. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 887K
n/a 3M change
n/a 12M change
Total Value Held $7.02 Million

Ben R Taylor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Payment of exercise price or tax liability
$47,444 $7.25 p/Share
6,544 Reduced 0.73%
886,606 Class A Common Stock
Feb 03 2025
BUY
Grant, award, or other acquisition
-
48,940 Added 5.19%
893,150 Class A Common Stock
Dec 19 2024
BUY
Grant, award, or other acquisition
-
370,343 Added 30.49%
844,210 Class A Common Stock
Dec 17 2024
SELL
Payment of exercise price or tax liability
$49,046 $6.95 p/Share
7,057 Reduced 1.47%
473,867 Class A Common Stock
Dec 16 2024
SELL
Payment of exercise price or tax liability
$94,634 $6.04 p/Share
15,668 Reduced 3.16%
480,924 Class A Common Stock
BRT

Ben R Taylor

Chief Financial Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX